{{Rsnum
|rsid=2048718
|Gene=BRIP1
|Chromosome=17
|position=61863458
|Orientation=plus
|GMAF=0.494
|Gene_s=BRIP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 36.3 | 49.6 | 14.2
| HCB | 5.8 | 31.4 | 62.8
| JPT | 2.7 | 40.7 | 56.6
| YRI | 71.4 | 27.2 | 1.4
| ASW | 47.4 | 47.4 | 5.3
| CHB | 5.8 | 31.4 | 62.8
| CHD | 3.7 | 31.2 | 65.1
| GIH | 5.0 | 51.5 | 43.6
| LWK | 54.5 | 35.5 | 10.0
| MEX | 20.7 | 36.2 | 43.1
| MKK | 59.6 | 30.8 | 9.6
| TSI | 40.2 | 43.1 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=23473757
|Title=BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer
}}

{{PMID Auto
|PMID=15113441
|Title=Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
|OA=1
}}

{{PMID Auto
|PMID=17342202
|Title=Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
|OA=1
}}

{{PMID Auto
|PMID=19138047
|Title=Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan.
|OA=1
}}

{{PMID Auto
|PMID=24301948
|Title=Further evidence for the contribution of the BRCA1-interacting protein-terminal helicase 1 (BRIP1) gene in breast cancer susceptibility
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}